Cargando…

Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ

BACKGROUND: Management advice for women with lobular carcinoma in situ (LCIS) is hampered by the lack of accurate personalised risk estimates for subsequent invasive breast cancer (BC). Prospective validation of the only tool that estimates individual BC risk for a woman with LCIS, the International...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lo, Louisa Lisa, Milne, Roger Laughlin, Liao, Yuyan, Cuzick, Jack, Terry, Mary Beth, Phillips, Kelly-Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035272/ https://www.ncbi.nlm.nih.gov/pubmed/29925933 http://dx.doi.org/10.1038/s41416-018-0120-z

Ejemplares similares

Ibis
por: Vargas Vila, José María, 1860-1933
Publicado: (1908)

Molecular drivers of lobular carcinoma in situ
por: Logan, Greg J., et al.
Publicado: (2015)

Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I)
por: Smith, Samuel George, et al.
Publicado: (2017)

Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial
por: Hale, Michael J., et al.
Publicado: (2020)

Off-treatment bone mineral density changes in postmenopausal women receiving anastrozole for 5 years: 7-year results from the IBIS-II prevention trial
por: Sestak, Ivana, et al.
Publicado: (2021)

Genetic analysis of lobular carcinoma in situ and associated invasive lobular cancer
por: Yates, LR, et al.
Publicado: (2010)

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
por: Forbes, John F, et al.
Publicado: (2016)

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial
por: Cuzick, Jack, et al.
Publicado: (2015)

Comparison of the Imaging Features of Lobular Carcinoma In Situ and Invasive Lobular Carcinoma of the Breast
Publicado: (2021)

Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial
por: Cuzick, Jack, et al.
Publicado: (2020)

The diagnosis and management of pre-invasive breast disease: Pathology of atypical lobular hyperplasia and lobular carcinoma in situ
por: Simpson, Peter T, et al.
Publicado: (2003)

The spreading of the invasive sacred ibis in Italy
por: Cucco, Marco, et al.
Publicado: (2021)

Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions
por: Andrade, Victor P, et al.
Publicado: (2012)

Germline CDH1 mutations in bilateral lobular carcinoma in situ
por: Petridis, C, et al.
Publicado: (2014)

Granulomatous lobular mastitis associated with ductal carcinoma in situ of the breast
por: Oddó, David, et al.
Publicado: (2019)

Imaging Spectrum of Lobular Carcinoma In Situ and Correlation with Pathology Findings
por: Hande, Pradipta C, et al.
Publicado: (2021)

Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade
por: Lee, Jeea, et al.
Publicado: (2022)

The Sacred Ibis debate: The first test of evolution
por: Curtis, Caitlin, et al.
Publicado: (2018)

The Genomic Footprints of the Fall and Recovery of the Crested Ibis
por: Feng, Shaohong, et al.
Publicado: (2019)

Relationships between CYP2D6 phenotype, breast cancer and hot flushes in women at high risk of breast cancer receiving prophylactic tamoxifen: results from the IBIS-I trial
por: Sestak, I, et al.
Publicado: (2012)

Clonal relationships between lobular carcinoma in situ and other breast malignancies
por: Begg, Colin B., et al.
Publicado: (2016)

Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review
por: Wazir, Umar, et al.
Publicado: (2016)

Lobular Carcinoma In Situ Incidentally Detected by Dual-Energy Computed Tomography
por: Erdemir, Ahmet Gürkan, et al.
Publicado: (2022)

Correction: The Sacred Ibis debate: The first test of evolution
Publicado: (2018)

Ibis T5000: a universal biosensor approach for microbiology
por: Ecker, David J., et al.
Publicado: (2008)

IBI: Identification of Biomarker Genes in Individual Tumor Samples
por: Li, Jie, et al.
Publicado: (2019)

Improving decision making about clinical trial participation – a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trial
por: Juraskova, I, et al.
Publicado: (2014)

The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family Registry
por: Cloud, Ann J., et al.
Publicado: (2015)

Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene
por: Rahman, N, et al.
Publicado: (2000)

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
por: Vos, C. B., et al.
Publicado: (1997)

Collagenous Spherulosis Associated with Lobular Carcinoma In Situ of the Breast: Two Case Reports
por: Kim, Ga-Eon, et al.
Publicado: (2018)

A case of fibroadenoma with lobular carcinoma in situ and microinvasion in a young woman
por: Wang, Mingjia, et al.
Publicado: (2022)

Integrated Box Interrogation System (IBIS) Preliminary Design Study
por: Croft, S, et al.
Publicado: (2003)

Pleural diseases and COVID-19: ubi fumus, ibi ignis
por: Porcel, José M.
Publicado: (2020)

Signatures of Crested Ibis MHC Revealed by Recombination Screening and Short-Reads Assembly Strategy
por: Chang, Liao, et al.
Publicado: (2016)

Increased levels of active c-Src distinguish invasive from in situ lobular lesions
por: Zou, Donghui, et al.
Publicado: (2009)

Breast cancer after prophylactic mastectomy for Lobular Carcinoma-In-Situ (LCIS) - an unusual case
por: Gurjar, N, et al.
Publicado: (2012)

PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression
por: Shah, Vandna, et al.
Publicado: (2017)

Lobular carcinoma in situ of the breast – correlation between minimally invasive biopsy and final pathology
por: Szynglarewicz, Bartłomiej, et al.
Publicado: (2016)

Solitary Orbital Metastasis 35 Years after a Diagnosis of Lobular Carcinoma in Situ
por: Spraker, Matthew B, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4gbroo69u11v4p2vbcn06rnogs